RESMED INC — Director's Dealing 2008

May 6, 2008

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

OMB APPROVAL

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

OMB Number: 3235-0287 Expires: February 28, 2011
Expires: February 28, 2011 per response 0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person	2. Issuer Name and Ticker or Trading Symbol	5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
FARRELL PETER C (Last) (First) (Middle)	RESMED INC [RMD]	A Director J 10% Owner
14040 Danielson Street	3. Date of Earliest Transaction (Month/Day/Year)	Al Officer $\Box$ Other (give title below) (specify below) Exec. Chairman of the Board
(Street) CA 92064 Poway	05/05/2008
(City) (State) (Zip)	4. If Amendment, Date Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line)
		A Form filed by One Reporting Person
		Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1. Title of Security (1nstr. 3)	2. Transaction Date (Month/Day/Year)	2A, Deemed Execution Date, if any (Month/Day/Year)	Transaction l Code ${Instr.8}$	4. Securities Acquired (A) or Disposed of (D) (Instr. 3.4 and 5)			l 5. Amount of Securities Beneficially Owned (D) or Indirect Beneficial Following Reported (1) (Instr. 5) Transaction(s) $($ lnstr. 3 and 4 $)$	16. Ownership l Form: Direct.	7. Nature of Indirect Ownership (Instr. 5)
			Code	Amount	l (A). .or (D)	I Price
ResMed Common Stock	05/05/2008			5.000'	Ð	\$41,0509	809.062	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

l 1. Title of Security $\lfloor$ (lnstr. 3) $\rfloor$	Derivative Conversion for Exercise I Price of I Derivative Security	3. Transaction Date 3A. Deemed [4] (Month/Day/Year) Execution	Date if any l (Month/ Day /Year)	ITransaction lof [Code (Instr. Derivative 18)		15. Number Securities l Acauired $(A)$ or Disposed of (D) (Instr. 13, 4, and 5).		6. Date Exercisable and 7. Title and Expiration Date (Month/Day/Year)		I Amount of Underlying Security (Instr. 3 and		Derivative Derivative Security l (Instr. 5)	8. Price of 19. Number of 110. Securities Beneficially lOwned i l Followina Reported Transaction $(s)$ (Instr. 4)	Ownership Form: Direct(D) or Indirect l(I) (Instr.	11. Nature lof Indirect Beneficial Ownership $l$ (Instr. 4)
				[Code		(A)	(O)	Date Exercisable Date	Expiration Title Amount		Number lot l Shares

Explanation of Responses:

1. Parsuaut to existing 1005-1 plan.

Peter C. Farrell

05/05/2008

Signature of Reporting Person

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.